A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate, The Journal of Maternal-Fetal & Neonatal Medicine, 21:1, 9-23, DOI: 10.1080/14767050701830480 To link to this article: https://doi.org/10.1080/14767050701830480 Abstract Introduction. Accumulating evidence suggests that an imbalance between pro-angiogenic (i.e., vascular endothelial growth factor (VEGF) and placental growth factor (PlGF)) and anti-angiogenic factors (i.e., soluble VEGF receptor-1 (sVEGFR-1, also referred to as sFlt1)) is involved in the pathophysiology of preeclampsia (PE). Endoglin is a protein that regulates the pro-angiogenic effects of transforming growth factor b, and its soluble form has recently been implicated in the pathophysiology of PE. The objective of this study was to determine if changes in maternal plasma concentration of these angiogenic and anti-angiogenic factors differ prior to development of disease among patients with normal pregnancies and those destined to develop PE (preterm and term) or to deliver a small for gestational age (SGA) neonate. Methods. This longitudinal nested case-control study included 144 singleton pregnancies in the following groups: (1) patients with uncomplicated pregnancies who delivered appropriate for gestational age (AGA) neonates (n ¼ 46); (2) patients who delivered an SGA neonate but did not develop PE (n ¼ 56); and (3) patients who developed PE (n ¼ 42). Longitudinal samples were collected at each prenatal visit, scheduled at 4-week intervals from the first or early second trimester until delivery. Plasma concentrations of soluble endoglin (s-Eng), sVEGFR-1, and PlGF were determined by specific and sensitive ELISA. Results. (1) Patients destined to deliver an SGA neonate had higher plasma concentrations of s-Eng throughout gestation than those with normal pregnancies; (2) patients destined to develop preterm PE and term PE had significantly higher concentrations of s-Eng than those with normal pregnancies at 23 and 30 weeks, respectively (for preterm PE: p 5 0.036 and for term PE: p ¼ 0.002); (3) patients destined to develop PE (term or preterm) and those who delivered an SGA neonate had lower plasma concentrations of PlGF than those with a normal pregnancy throughout gestation, and the maternal plasma concentration of this analyte became detectable later among patients with pregnancy complications, compared to normal pregnant women; (4) there were no significant differences in the plasma concentrations of sVEGFR-1 between patients destined to deliver an SGA neonate and those with normal pregnancies; (5) patients destined to develop preterm and term PE had a significantly higher plasma concentration of sVEGFR-1 at 26 and 29 weeks of gestation than controls (p ¼ 0.009 and p ¼ 0.0199, respectively); and (6) there was no significant difference in the increment of sVEGF...

The Institute of Medicine's gestational weight gain guidelines are intended to reduce pregnancy complications, poor birth outcomes and excessive postpartum weight retention. The specific weight gain guidelines vary by prepregnancy weight status. We evaluated the validity of prepregnancy weight status (underweight, normal weight, overweight and obesity) classified from self-reported prepregnancy height and weight in reference to those from measured data during the first trimester of pregnancy and imputed data for both pregnant and age-matched non-pregnant women included in the National Health and Nutrition Examination Survey 2003-2006. Self-reported prepregnancy weight status was validated by two ideal references: imputed data with the number of imputations as 10 (n = 5,040) using the data of age-matched non-pregnant women who had both self-reported and measured data, and weight status based on height and weight measured during the first trimester (n = 95). Mean differences, Pearson's correlations (r), and Kappa statistics (κ) were used to examine the strength of agreement between self-reported data and the two reference measures. Mean (standard error of the mean) differences between self-reported versus imputed prepregnancy weight was -1.7 (0.1) kg with an r = 0.98 (p < 0.001), and κ = 0.78 which indicate substantial agreement for the 504 pregnant women. Mean (SEM) differences between self-reported prepregnancy weight versus measured weight in the first trimester was -2.3 (0.7) kg with r = 0.98 (p < 0.001), and κ = 0.76, which also showed substantial agreements in 95 pregnant women. Prepregnancy weight status classified based on self-reported prepregnancy height and weight was valid.

The finding of measurement bias associated with type of trauma raises questions about the applicability of a single definition for PTSD associated with assaultive violence and PTSD associated with traumatic events of lesser magnitude.

We investigate the impact of pubertal development, age, and its interaction on female substance use behaviour. An extended latent transition model with two latent variables is used to reflect the dependency of adolescent substance use on pubertal development and age. A sample of females in grades 7-12 is analysed using maximum-likelihood estimation. Analyses indicate that experiencing puberty is related to increased substance use for all age groups. Among females aged 12-15, those who have experienced puberty are more likely to advance in substance use compared to their late-maturing counterparts. Particularly, among 12-year old non-substance users, those who have experienced puberty are approximately three times more likely to advance towards substance use than those who have not experienced puberty. In addition, among older females, those whose puberty is in progress are more prone to advance in substance use compared to those whose puberty has not occurred.

A simplified systematic imaging approach, in the order signal intensity, size and depth, would be a reference to distinguish between benign and malignant soft-tissue tumours for non-experts.

Inconsistent findings linking placental histologic chorioamnionitis (HCA) and preterm delivery may result from variations in HCA definition, population studied, and exclusion criteria. This analysis from the 1998-2004 Pregnancy Outcomes and Community Health Study (five Michigan communities) includes the first 1,053 subcohort women (239 preterm, 814 term) with completed placental assessments. Multiple HCA definitions were constructed by 1) varying polymorphonuclear leukocytes/high-powered field thresholds and placenta components included and 2) using polymorphonuclear leukocyte characteristics to assign low/high maternal, fetal inflammation stage and grade. In African Americans, HCA was associated with preterm delivery before 35 weeks. The effect size was modest for polymorphonuclear leukocytes/high-powered field thresholds of greater than 10 and greater than 30 (odds ratios (ORs) ¼ 0.8 and 2.0); larger for greater than 100 (OR ¼ 3.2, 95% confidence interval (CI): 1.4, 7.1); strengthened after excluding medically indicated preterm deliveries (OR ¼ 4.9, 95% CI: 2.0, 11.8); and strongest for high maternal/high fetal HCA (OR ¼ 5.6, 95% CI: 1.4, 22.1). These latter HCA criteria also produced the largest effect size in Whites/others (OR ¼ 2.7, 95% CI: 0.3, 26.9). Among preterm deliveries before 35 weeks excluding those medically indicated, 12% of Whites/others and 55% of African Americans had high maternal HCA. The authors conclude that HCA definition, exclusion criteria, and race/ethnicity influence the HCA-preterm delivery association and that HCA contributes to preterm delivery-related ethnic disparity.

The authors examined the associations between placental vascular findings and preterm delivery in 1,053 subcohort women (239 preterm, 814 term) from a Michigan pregnancy cohort study (1998-2004). Twenty-nine placental vascular variables from microscopic examinations were grouped into 5 constructs: 3 maternal constructs-obstructive lesions (MV-O), bleeding/vessel integrity (MV-I), and lack of physiologic conversion of maternal spiral arteries (MV-D)--and 2 fetal constructs--obstructive lesions (FV-O) and bleeding/vessel integrity (FV-I). Construct-specific scores were created by adding the number of positive findings and deriving a dichotomous variable to approximate the top quintile ("high") and bottom 4 quintiles ("not high") within each construct. In multivariate polytomous logistic regression models, medically indicated preterm delivery at <35 weeks was significantly associated with high scores for each of the vascular constructs; adjusted odds ratios ranged from 2.4 to 5.4. Spontaneous preterm delivery at 35-36 weeks was significantly associated with a high score on any 1 of 3 constructs: MV-I, MV-D, and FV-I. Spontaneous preterm delivery at <35 weeks was significantly associated with a high score on 2 or more of 3 constructs: MV-I, MV-D, and FV-I; adjusted odds ratios ranged from 4.1 to 7.4. These results support a role for various placental vascular lesions in medically indicated and spontaneous preterm delivery.

The gestational weight gain (GWG) guidelines of the Institute of Medicine (IOM) aim to optimize birth outcomes and reduce pregnancy complications. The GWG guidelines are set based on the prepregnancy weight status and optimal weight gain at different trimesters of pregnancy. Dietary references intakes (DRIs) of the IOM are set for each trimester of pregnancy for energy intake and other essential nutrients by age groups (≤ 18, 19-30, 31-51 years). The DRIs, however, do not take into account the differing energy and nutrient requirements of women with different prepregnancy weights. In this cross-sectional study, we tested the hypothesis that diet quality during pregnancy is associated with adequate GWG at different stages of pregnancy. Diet quality during pregnancy was assessed from a 24-h recall measured by the healthy eating index of 2005 (HEI-2005). Both GWG and diet quality data were from 490 pregnant women aged 16-43 years included in National Health and Nutrition Examination Survey 2003-2006, a program of studies designed to assess the health and nutritional status of adults and children in the US, during which pregnant women were oversampled. Logistic regression models adjusted for age, trimester of gestation, race/ethnicity, education level, marital status, family poverty income ratio, daily supplement use, physical activity, and prepregnancy BMI were used to investigate if HEI-2005 is a determinant of GWG status at different trimesters of pregnancy. We found that HEI-2005 scores were not determinants of adequate GWG, although inadequate intake of total vegetables (OR 3.8, CI 1.1-13.2, p = 0.03) and oils were associated with excessive GWG (OR 2.8, CI 1.2-6.4, p = 0.02) when covariates were controlled. Although adequate GWG was not associated with diet quality as measured by HEI-2005 during pregnancy in this study, comprehensive prenatal counseling is still important to reduce adverse birth outcomes.